Ascom (ASCN) H2 2025 earnings summary

Executive summary

• Net revenue reached CHF 292.1 million in 2025, up 3.8% at constant currencies, with strong growth in EBITDA and net profit compared to 2024.

• EBITDA increased by 60% to CHF 34.3 million, with margin improving to 11.7% from 7.4% in 2024.

• Net profit grew to CHF 15.1 million, with EPS at CHF 0.43 and equity ratio at 40%.

• Major organizational redesign consolidated regions and improved efficiency, supporting operational improvements across all segments.

• Delivered major customer projects in acute care, long-term care, and enterprise, supporting digitalization and efficiency.

Financial highlights

• Gross profit margin increased to 48%, with gross profit at CHF 140.8 million.

• Free cash flow improved to CHF 21.8 million, and operating cash flow rose to CHF 32.6 million.

• Net cash position at year-end was CHF 29.6 million, with no outstanding borrowings.

• Capex decreased to 11.1% of revenue, mainly due to completion of refurbishment projects.

• CHF 10.4 million returned to shareholders via share buyback and dividends.

Outlook and guidance

• 2026 guidance: low to mid-single-digit revenue growth at constant currencies and EBITDA margin of 10%-12%.

• Focus for 2026 includes leveraging new organization, operational improvements, and accelerating innovation.

• No midterm goals issued due to global uncertainty and ongoing business review by new CEO.